- The dental workforce trends that will dominate 2026
- Federal Medicaid cuts threaten dental care access: See the potential impact by state
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- Think bigger – Turning AI from Trends to Long-Term Transformation
- UnityPoint Health hospital names market chief nursing officer
- OhioHealth builds well-being programs to reshape caregiver culture
- Washington hospital staff vote ‘no confidence’ in management company
- U of Mississippi Medical Center restores phone lines after cyberattack
- 13 health system IT leadership moves
- How health systems are repositioning informatics
- Mississippi hospital names COO
- Ex-Amazon Health leader joins Spotify founder’s health tech startup
- Know the True Value of Your Lab When an Offer Is on the Table
- U of California offers 32% wage hike in union talks
- UF Health taps new outpatient senior VP
- UAMS names new director of cardiovascular medicine division
- CMS’ add-on billing code boosts specialist pay: Study
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- Florida medical center to expand with ASC
- New Jersey woman charged with practicing unlicensed dentistry
- CMS extends hospital-at-home waivers for 5 years: What ASCs need to know
- 100+ organizations call on CMS to revise 2027 MA rates
- The retention breakthrough anesthesia needs
- Oklahoma advances interstate compact bill
- Brown University Health names new chief of cardiac surgery
- UNC Health Appalachian offers psychiatric physician training program
- Former PepperPointe Partnerships COO joins DPO
- The Smilist expands into Virginia
- Physician-led orthopedic ASC opens in Florida
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- Georgia opens 30-bed forensic mental health unit to ease jail backlog
- Pennsylvania county cuts ribbon on $19.8M mental health diversion center
- Outpatient cardiology’s CMS whiplash
- 12 new ASCs in February
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- 15 dentists making headlines
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 10 providers seeking RCM talent
- PDS Health added de novos across 3 states in February
- Novant posts 4.8% operating margin in 2025
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- Cleveland Clinic posts $913M operating income, 5% margin — 7 things to know
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Clinician Engagement: The Operating Lever Behind Margin and Throughput
- Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- 11 behavioral health executive moves to know
- 3 behavioral healthcare M&A deals in 2026
- Anthem Blue Cross of California pushes E/M downcoding policy to April
- Iowa dentist surrenders license
- Temple University gets approval for $3.19M rural dental clinic
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds
- How the Brain Learns to Have Seizures During Sleep
- Blood Test Can Predict Short-Term Survival Among Seniors
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- As SCOTUS takes on 'skinny label' review, top US lawyer sides with generics maker
- Lake Nona Impact Forum: There can't be longevity without tech
- Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up
- Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Partnering to Advance Drug Delivery Innovation
- What the Health? From KFF Health News: What About the State of Health?
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
- Frozen Blueberry Recall Issued Across Four States for Listeria
- Boehringer's Hernexeos secures speedy first-line expansion in FDA's 2nd national priority nod
- 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Cientos de enfermeros estadounidenses dejan atrás el Estados Unidos de Trump y eligen trabajar en Canadá
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Could Drone-Delivered Defibrillators Save Lives?
- Inflammation Linked To Brain Damage, Memory Problems Among Football Players
- Early Birds, Active Folks Less Likely To Develop ALS
- Disasters Can Affect Mental Health A Decade Later, Review Finds
- AI Chatbots Can Contribute To Worsening Mental Illness, Study Finds
- Newborns Exposed to More ‘Forever Chemicals’ Than Once Thought
- Study Highlights Unique Parenting Struggles of Younger Patients With Heart Disease
- Altman-backed startup Verifiable rolls out AI agent to automate credentialing
- ‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada Over Trump’s America
- ‘Kind of Morbid’: Health Premiums Threaten Their Nest Egg. A Terminal Diagnosis May Spare It.
While Big Pharma has launched an all out campaign to oust Robert F. Kennedy, Jr. and his MAHA supporters from government, the global processed food industry has taken a much more accommodating tack:
https://www.politico.com/news/2025/09/13/maha-kennedy-trump-food-industry-washington-00561830
Publicly, this industry has been mostly quiet about MAHA. Privately, they’re panicking.
Major food companies are struggling to maintain decades-old alliances as the Make America Healthy Again movement tightens its grip on the GOP.
By Marcia Brown - September 13, 2025Some of the world’s biggest food companies are confronting a strange reality in Washington: They’re no longer getting their way.
After decades of seeing glad-handing on Capitol Hill and positive relations with the White House pay off in policy wins, food industry lobbyists are finding fewer receptive audiences and even struggling to get key meetings as consumer trends and a triumphant political movement fracture old alliances.
“Most of the food industry is like the stunned fish you get when you stick a cattle prod in a fish pond,” said one long-time food industry lobbyist granted anonymity to speak candidly.
The White House’s plan to improve children’s health, released Tuesday, is the clearest signal yet that Robert F. Kennedy Jr.’s Make America Healthy Again agenda is scrambling the equation for how K street wields its influence, leaving the food industry divided and confused.
While farm groups were able to persuade the White House to dial back its criticism of pesticides, companies that manufacture processed foods are instead seeing the Health and Human Services secretary pushing front-of-pack nutrition labeling, tighter regulations of ultra-processed foods and new limits on additives — all changes that could have significant financial implications for their trillion-dollar industry.
“These are not surprises,” said a second industry representative granted anonymity to speak candidly. “But that doesn’t mean that … this is not still a fundamental change in some things for the industry that we’re going to have to be prepared to deal with.
This account, which is based on nine interviews with representatives across the food and consumer packaged goods industry, paints a picture of a food sector at war with itself over how to respond to White House attacks — or whether to respond at all.
Tuesday’s MAHA strategy report comes as the industry is facing sweeping changes: Weight-loss drugs are shrinking serving size, states are banning ultra-processed foods from school lunches and tariffs are decimating profit margins.
Though it didn’t meaningfully change the administration’s position on food additives or labeling, some in the industry thought the MAHA strategy report represented a shift. For one, some in the industry were invited to share feedback before its publication. At the report’s launch, White House Domestic Policy Council Director Vince Haley even namechecked “recommendations from industry.” But most lobbyists are still skeptical that it’s anything more than “a bright spot,” as a third person described it.
It wouldn’t be the first time Kennedy offered an olive branch to industry without much changing his position.
He asserted during his Senate confirmation hearing in January that regulators were allowing top food brands like McDonald’s to “mass poison American children.” But two months later, he was doing a television hit at Steak ‘n Shake praising the company’s decision “RFK’ing the french fries” — swapping vegetable oil for beef tallow.
The apparent contradiction is leaving the food industry floundering. A fourth industry lobbyist said it was part of the White House’s strategy to “keep folks on their heels.”
While some parts of the food industry have won praise from administration officials for making voluntary commitments that align with White House priorities, others are struggling with their approach. Several groups and companies have shied away from publicly criticizing the administration out of fear they could become the focus of a presidential social media post, which could color consumer sentiment against their products.
In April, the American Beverage Association — a trade group representing Coca-Cola and PepsiCo among others — criticized the Trump administration for supporting a ban on food stamp recipients purchasing soda with their benefits.
Calley Means, who serves under Kennedy as a special government employee at the Department of Health and Human Services, immediately shot back: “You have lobbied millions to ensure taxpayer money funds soda for poor kids,” he posted on X.
Agriculture Secretary Brooke Rollins piled on. “It’s disappointing that the American Beverage Association’s leadership dragged its entire membership ... into direct conflict with this Administration’s priorities for American health, well-being, and taxpayer protection.”
The episode left an impression.
“There’s a keen hesitance to say anything and call a spade a spade,” said a fifth industry representative. “That’s a very different universe. Since when do big companies refrain?”
While many member companies want their trade associations to push back, the groups have largely shied away from public criticism, opting instead for voluntary commitment pledges, such as removing food dyes.
A sixth industry representative noted the surprising absence of an industry coalescing around a single mission to counter the administration.
“The rise of this sort of anti-institution sentiment and antigovernment, anti-everything has had an impact on the food industry’s ability to exert their influence,” the person added.
At the MAHA Commission’s news conference Tuesday, Rollins lauded the dairy industry for committing to cut artificial dyes from its products “even though it might hurt” companies’ bottom lines. The Trump administration is even tracking company and trade group commitments to eliminate such additives on the FDA’s website.
Groups like the Consumer Brands Association, which represents food companies like General Mills and Nestlé, are announcing voluntary programs to encourage members to eliminate artificial food dyes — over the objections of some companies. Still, other groups like the American Beverage Association are attempting to ratchet up consumer transparency by listing ingredients their members use that weren’t previously disclosed, allowed by what critics see as a loophole in the Food and Drug Administration’s regulations.
Despite these efforts, Kennedy continues to disparage their products, repeatedly saying that some of America’s most popular food items are making people sick. That rhetoric — even if it’s yet to be accompanied by serious regulatory change — has become increasingly difficult for the industry to counter. Many food lobbyists privately express similar concerns to Kennedy about chronic disease though they argue that the MAHA Commission’s proposals will do little to solve it.
And the industry recognizes that going after sugary drinks and processed food is popular across the political spectrum, making it an easy target despite company pledges to appease Kennedy on food dyes, seed oils and more.
Said a seventh lobbyist: “Is this a distraction because vaccines are so politically polarizing and there’s wins to be had here, so they’re going to come back for more?”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















